Cryoglobulins in chronic hepatitis C virus infection

Clinical and Experimental Immunology

Volumn 133, Issue 2, 2003, Pages 153-155

  Trendelenburg, M ^a   Schifferli, J A ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS RNA;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; CRYOGLOBULINEMIA; CRYOPRECIPITATION; HEPATITIS C; HEPATITIS C VIRUS; LYMPHOMA; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; VASCULITIS; VIRUS INFECTION; VIRUS LOAD;

ANTIGEN-ANTIBODY COMPLEX; CRYOGLOBULINEMIA; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

EID: 0041665156     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02198.x     Document Type: Review

References (28)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-62
2. Kuo G, Choo QL, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244:362-4
3. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162:569-70
4. Ferri C, Greco F, Longombardo G, Palla P, Marzo E, Moretti A. Hepatitis C virus antibodies in mixed cryoglobulinemia. Clin Exp Rheumatol 1991; 9:95-6
5. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327:1490-5
6. Dammacco F, Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol 1992; 87:352-6
7. Pechere-Bertschi A, Perrin L, de Saussure P, Widmann JJ, Giostra E, Schifferli JA. Hepatitis C: a possible etiology for cryoglobulinaemia type II. Clin Exp Immunol 1992; 89:419-22
8. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974; 57:775-88.
9. Tissot JD, Invernizzi F, Schifferli JA, Spertini F, Schneider P. Two-dimensional electrophoretic analysis of cryoproteins, a report of 335 samples. Electrophoresis 1999; 20:606-13.
10. Ivanovski M, Silvestri F, Pozzato G et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998; 91:2433-42.
11. Posnett DN, Edinger J. When do microbes stimulate rheumatoid factor? J Exp Med 1997; 185:1721-3.
12. Levy S, Todd SC, Maecker HT. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 1998; 16:89-109.
13. Pileri P, Uematsu Y, Campagnoli S et al. Binding of hepatitis C virus to CD81. Science 1998; 282:938-41.
14. Racanelli V, Sansonno D, Piccoli C, D'Amore FP, Tucci FA, Dammacco F. Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol 2001; 167:21-9.
15. Kitay-Cohen Y, Amiel A, Hilzenrat N et al. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 2000; 96:2910-2.
16. Zuckerman E, Zuckerman T, Sahar D et al. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 2001; 97:1555-9.
17. Zignego AL, Ferri C, Giannelli F et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002; 137:571-80.
18. De Vita S, De Re V, Sansonno D et al. Lack of HCV infection in malignant cells refutes the hypothesis of a direct transforming action of the virus in the pathogenesis of HCV-associated B-cell NHLs. Tumori 2002; 88:400-6.
19. Qi M, Steiger G, Schifferli JA. A calcium-dependent cryoglobulin IgM kappa/polyclonal IgG. J Immunol 1992; 149:2345-51.
20. Barton JC, Herrera GA, Galla JH, Bertoli LF, Work J, Koopman WJ. Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin. Am J Med 1987; 82:624-9.
21. Odum J, D'Costa D, Freeth M, Taylor D, Smith N, MacWhannell A. Cryoglobulinaemic vasculitis caused by intravenous immunoglobulin treatment. Nephrol Dial Transplant 2001; 16:403-6.
22. Sansonno D, Lauletta G, Nisi L et al. Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulimaemia. Clin Exp Immunol 2003; 133:275-82.
23. Madi N, Steiger G, Estreicher J, Schifferli JA. Defective immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with mixed essential cryoglobulinemia type II. J Immunol 1991; 147:495-502.
24. Ng YC, Peters DK, Walport MJ. Monoclonal rheumatoid factor-IgG immune complexes. Poor fixation of opsonic C4 and C3 despite efficient complement activation. Arthritis Rheum 1988; 31:99-107.
25. Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997; 25:1237-44.
26. Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997; 40:2007-15.
27. Fulpius T, Berney T, Lemoine R et al. Glomerulopathy induced by IgG3 anti-trinitrophenyl monoclonal cryoglobulins derived from non-autoimmune mice. Kidney Int 1994; 45:962-71.
28. Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon-α with an anti-CD20. Blood 2002; 101:3818-26.